期刊文献+

复发脑胶质瘤再手术疗效的影响因素分析 被引量:13

Clinical analysis of prognostic factors in re-operation for recurrent glioma
下载PDF
导出
摘要 目的探讨复发脑胶质瘤再手术的适应证及预后影响因素。方法对42例复发脑胶质瘤接受再手术的临床资料进行回顾性分析。结果24例为镜下全切除,18例为次全或大部分切除,无手术死亡病例;再手术前卡氏预后评分(Karnofsky Performance Status,KPS)平均(74.5±11.7)分,再手术后平均(82.3±11.6)分;再手术后生存期为2~87个月,平均(21.2±3.7)个月。经单因素分析再次手术前KPS评分、初次术后病理级别、发现病灶复发时距初次手术的时间、再手术肿瘤切除程度及再次手术后辅助治疗是影响再次术后生存期的因素;多因素分析提示再次术前KPS评分高、发现病灶复发时距初次手术的时间长是预后保护因素,而再次术后病理级别高为预后的危险因素。结论术前KPS≥70分,病理WHOⅠ-Ⅱ级,发现病灶复发时距初次手术的时间≥6个月的复发脑胶质瘤患者再手术治疗效果较好。 Objective To investigate indications, prognostic factors of the patients undergoing re-operation for recurrent intracranial gliomas. Method Clinical data of 42 patients receiving reoperation with recurrent intracranial gliomas were retrospectively analyzed. Results Twenty-four cases underwent total tumor resection and 18 cases had subtotal tumor removal, respectively. There was no surgery related death in this group of patients. The mean scores for the Kamofsky performance status (KPS) were significantly increased from 74.5 to 82.3 after re-operation. The survival time of the patients after re-operation was 2 to 87 months (mean 21.2 months). Univariate analysis showed that the KPS score before re-operation, primary pathologic grade, interval between primary operation and focal recurrence, surgical excision extent in the re-operation and adjunctive therapy following re-operation were related with the survival time after re-operation. Multivariate analysis showed that the higher KPS score before re-operation and longer interval between primary operation and focal recurrence were favorable factors for the prognosis, while the higher pathologic grade of the tumor at the secondary surgery was risk factor. Conclusion Re-operation is effective for the recurrent glioma patients with the KPS score ≥ 70 before re-operation, interval between primary operation and focal recurrence ≥ 6 months and pathologic diagnosis of WHO grade I - II.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2012年第1期36-39,共4页 Chinese Journal of Nervous and Mental Diseases
关键词 脑胶质瘤 复发 手术 适应证 Intracranial glioma Recurrence Operation Indication
  • 相关文献

参考文献2

二级参考文献13

  • 1[2]Macdonald DR. New frontiers in the treatment of malignant gliomas [J]. Semin Oncol, 2003, 30(6suppl 19): 72-76.
  • 2[3]Hentschel S J, Lang FF. Current surgical management of glioblastoma [J]. Cancer J, 2003, 9(2): 113- 125.
  • 3[4]Youmans JR. Neurological Surgery [M]. Philadelphia: WB Saunders Company, 1996:2521 - 2522.
  • 4[5]Grossman RG, Loftus CM. Primary intrinsic tumors of the brain [M]. Princinples of Neurosurgery, Second edition, Philadephia,1999, 474 - 483.
  • 5[6]Hess KR. Extent of resection as a prognostic variable in the treatment of gliomas [J]. J Neurooncol, 1999,42(3):227-231.
  • 6[7]Davis F, Freels S, Grutsch J, et al. Survival rates in patients with primary malignant brain tumors straitified by patient age and tumor histological type: an analysis based on Surveillance,Epidemiology, and End Result (SEER) data, 1973-1991 [J]. J Neurosurgery, 1998, 88(1): 1-10.
  • 7[8]Schmidinger M, Linzmayer L, Becherer A, et al. Psychometric and quality-of-life assessment in long-term glioblastoma survivors [J].J Neurooncol, 2003, 63 ( 1 ): 55 - 61.
  • 8[9]Chang SM, Parney IF, McDermott M, et al. Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project [J]. J Neurosurg, 2003 98(6): 1175 - 1181.
  • 9[10]Botturi M, Fariselli L. Clinical results of unconventional fractionation radiotherapy in central nervous system tumors [J].Tumori, 1998, 84(2): 176 - 187.
  • 10[11]Glioma Meta-Analysis Trialists (GMT) Group. Chemotherapy for high-grade glioma[J]. Cochrane Database Syst Rev, 2002, (4):CD003913.

共引文献98

同被引文献133

引证文献13

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部